Trademark Overview
On Thursday, June 22, 2023, a trademark application was filed for PROVEN with the United States Patent and Trademark Office. The USPTO has given the PROVEN trademark a serial number of 98055522. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Tuesday, December 12, 2023. This trademark is owned by Entity Risk, Inc.. The PROVEN trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:
Computer software platforms, downloadable, for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; platform for building recommendations based on clinical evidence of benefit and risk; platform which expedites value assessment and provides qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting
Business consulting and information services; Business data analysis; Business data analysis services in the field of healthcare and pharmaceutical pricing and revenue; Providing business intelligence services; Subscription-based online retail store services in the field of healthcare and pharmaceutical business services; Organizational services for business purposes, namely, organizing data to help innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; platform for building recommendations based on clinical evidence of benefit and risk; platform which expedites value assessment and provides qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting
Design, development, and implementation of software for innovators to predict asset values, determine pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; platform for building recommendations based on clinical evidence of benefit and risk; platform which expedites value assessment and provides qualitative, evidence based approach to support decisions about pricing, evidence generation and contracting.; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) services featuring software for predicting business asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module
